Summary

Eligibility
for people ages 18-80 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UC Davis
Dates
study started
estimated completion
Principal Investigator
by Mohamed R Ali, MD (ucdavis)

Description

Summary

Evaluation of current and newly developed endoluminal therapies in the management of Upper and Lower GI conditions.

Official Title

Outcome Analysis of Endoluminal Therapies for Gastrointestinal Conditions Compared to Current Treatment Paradigms

Details

Over the last few years there have been numerous advances in the use of endoscopic equipment and related treatments in the identification and intervention of gastrointestinal diseases. Many of these treatments using flexible endoscopes have either complimented or replaced surgical approaches to these same benign and malignant disease processes with the potential of being the standard of care for many of these clinical conditions. The initial primary focus of this study will be the use of endoscopic myotomy for achalasia, endoscopic treatment of post bariatric weight gain, endoscopic gastro-gastric fistula treatments, and other endoluminal therapies for gastrointestinal and post-operative conditions. These treatments have been validated by prior surgery studies.

Keywords

Achalasia Gastric Fistula Weight Gain After Primary Weight Loss Surgery Marginal Ulcer Stenoses Gastric Nec Fistula Obesity POEM GERD endoscopic treatments post bariatric surger weight gain endoluminal Bariatric Surgery Barretts Esophageal Achalasia Peptic Ulcer Weight Loss Weight Gain Endoscopic Intervention

Eligibility

You can join if…

Open to people ages 18-80

  • Adult male and female patients 18-80 years of age
  • Meet the criteria for surgery of benign and/or malignant gastrointestinal pathology(s)
  • Gastrointestinal Reflux Disease
  • Achalasia
  • Barrett's Esophagus
  • Post Bariatric Surgery conditions
  • Other gastrointestinal and postsurgical disorders.

You CAN'T join if...

  • Adults unable to consent
  • Individuals that do not meet inclusion criteria or qualify for endoluminal treatment paradigms and internees.

Location

  • Univesity of California Davis Health System
    Sacramento California 95817 United States

Lead Scientist at UC Health

  • Mohamed R Ali, MD (ucdavis)
    Professor, Surgery. Authored (or co-authored) 55 research publications.

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
ID
NCT03123835
Study Type
Interventional
Last Updated